Nektar Therapeutics (NKTR) Balance Sheet
As of 2026-06-30 (10-Q), Nektar Therapeutics (NKTR) reported total assets of $1.1B, total liabilities of $192.0M and shareholders' equity of $903.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $39.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NKTRNektar TherapeuticsFollow NKTR — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.02 | 0.03 | 0.04 | 0.01 | 0.06 | 0.06 | 0.00 | 0.19 | 0.10 | 0.20 | 0.03 | 0.09 | 0.04 | 0.04 | 0.02 | 0.04 | |
| Short-term investments | 0.23 | 0.25 | 0.20 | 0.23 | 0.25 | 0.33 | 0.29 | 1.14 | 1.23 | 0.86 | 0.71 | 0.42 | 0.27 | 0.21 | 0.23 | 0.65 | |
| Receivables | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.04 | 0.04 | 0.04 | 0.02 | 0.01 | 0.00 | 0.00 | — | — | |
| Inventory | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | — | |
| Current assets | 0.28 | 0.31 | 0.26 | 0.29 | 0.35 | 0.43 | 0.33 | 1.44 | 1.42 | 1.14 | 0.80 | 0.55 | 0.33 | 0.26 | 0.27 | 0.74 | |
| Total assets | 0.61 | 0.50 | 0.43 | 0.44 | 0.50 | 0.57 | 0.51 | 2.15 | 1.98 | 1.54 | 1.12 | 0.71 | 0.40 | 0.30 | 0.28 | 1.10 | |
| Current liabilities | 0.28 | 0.08 | 0.10 | 0.06 | 0.06 | 0.07 | 0.06 | 0.08 | 0.35 | 0.12 | 0.09 | 0.07 | 0.05 | 0.06 | 0.05 | 0.07 | |
| Long-term debt | — | — | — | — | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | — | — | — | — | — | — | — | |
| Short-term debt | — | — | — | 0.00 | — | — | — | 0.00 | 0.25 | 0.00 | — | — | — | — | — | — | |
| Total liabilities | 0.41 | 0.45 | 0.52 | 0.41 | 0.49 | 0.48 | 0.42 | 0.43 | 0.57 | 0.46 | 0.44 | 0.34 | 0.27 | 0.24 | 0.19 | 0.19 | |
| Shareholders' equity | 0.20 | 0.05 | -0.09 | 0.04 | 0.01 | 0.09 | 0.09 | 1.72 | 1.41 | 1.08 | 0.68 | 0.37 | 0.13 | 0.06 | 0.09 | 0.90 |
USD billions · SEC XBRL
Nektar Therapeutics — questions
- How much cash does Nektar Therapeutics have?
- $39.3M in cash and cash equivalents as of 2026-06-30.
- What are Nektar Therapeutics's total assets?
- $1.1B as of 2026-06-30.
- What is Nektar Therapeutics's shareholders' equity?
- $903.1M as of 2026-06-30.
Every figure on this page comes from Nektar Therapeutics's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.